Annual Secretarial Compliance Report for the Year ended 31.03.2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gayatri BioOrganics Ltd has filed its Annual Secretarial Compliance Report for FY 2025-26, reviewed by Practicing Company Secretaries Vivek Surana & Associates. The report shows the company is largely compliant with SEBI regulations including LODR, ICDR, SAST, PIT, and Depositories regulations. One matter noted is that BSE had sought clarification on unusual price movement in March 2026, which the company attributed to normal market activity with no specific price-sensitive events. Additionally, a compliance issue flagged in the previous year regarding 100% dematerialization of promoter shareholding has been resolved—the company now reports full compliance with this requirement as of March 31, 2026.
This is a routine compliance filing indicating generally good standing with SEBI regulations. The resolution of the previous dematerialization issue is a positive development for shareholders, while the BSE price inquiry appears to be a standard regulatory check with no adverse findings.